Thioredoxin-1 inhibits granulosa cell ferroptosis to rescue ovarian aging through mitophagy-dependent activation of BNIP3L
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Ovarian aging is closely associated with a decline in fertility and an increase in reproductive dysfunction. Ovarian granulosa cells (GCs) support oocyte homeostasis and development, yet insight into GC dysfunction during aging is limited. Here, we show that aged GCs of humans and mice have indications of elevated ferroptosis, including increased ferroptosis-related metabolites, lipid peroxidation, and iron accumulation. The ferroptosis inhibitor Ferrostatin-1 reversed ovarian impairment and fertility of aged mice in vivo . We show that the age-related reduction in the expression of TXN (thioredoxin) leads to ferroptosis in human and mouse GCs by blocking BNIP3L-dependent mitophagy. Exogenous activation of TXN could promote mitophagy, thereby clearing excessive ROS and inhibiting ferroptosis. These results suggest that anti-ferroptosis-related treatments may assist in treating aging-related reproductive disorders.
Abstract Figure
Key points
-
Ferroptosis signatures are upregulated in aged GCs from human and mouse ovaries
-
TXN is deregulated in aged GCs, leading to mitochondrial and ROS metabolic dysfunction
-
TXN binds to DNA to regulate autophagy and mitophagy genes, including BNIP3L
-
Inhibition of ferroptosis can ameliorate GC dysfunction